Bromopride is a substituted benzamide derivative and a dopamine D2 receptor antagonist utilized as a prokinetic and antiemetic agent to treat gastrointestinal disorders such as nausea, vomiting, and gastroparesis.… Read more














Bromopride is a substituted benzamide derivative and a dopamine D2 receptor antagonist utilized as a prokinetic and antiemetic agent to treat gastrointestinal disorders such as nausea, vomiting, and gastroparesis. This category encompasses a comprehensive range of Bromopride reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these materials to perform rigorous impurity profiling, structural characterization, and analytical method validation. By utilizing these high-quality compounds, researchers can conduct precise quality control and stability testing, ensuring the integrity of the active pharmaceutical ingredient. These reference materials support adherence to regulatory guidelines regarding drug degradation pathways—such as hydrolysis, oxidation, and photolysis—facilitating accurate identification and quantification during routine analysis. Access to these specialized compounds is essential for maintaining consistent and reproducible results within pharmaceutical development and manufacturing environments.